{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:29:26Z","timestamp":1791181766524,"version":"4.1.0"},"reference-count":32,"publisher":"EDP Sciences","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1051\/medsci\/2006224405","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T12:24:13Z","timestamp":1299327853000},"page":"405-410","source":"Crossref","is-referenced-by-count":7,"title":["Ebola et Marburg : les homes contre-attaquent"],"prefix":"10.1051","volume":"22","author":[{"given":"Nathalie","family":"Alazard-Dany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Ottmann Terrangle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Volchkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2006,4,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Feldmann H, Wahl-Jensen V, Jones SM, Stroher U. Ebola virus ecology : a continuing mystery.Trends Microbiol2004; 12 : 433\u20137.","DOI":"10.1016\/j.tim.2004.08.009"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Leroy EM, Rouquet P, Formenty P,et al.Multiple Ebola virus transmission events and rapid decline of central African wildlife.Science2004; 303 : 387\u201390.","DOI":"10.1126\/science.1092528"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Rouquet P, Froment JM, Bermejo M,et al.Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003.Emerg Infect Dis2005; 11 : 283\u201390.","DOI":"10.3201\/eid1102.040533"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Baize S. A single shot against Ebola and Marburg virus.Nat Med2005; 11 : 720\u20131.","DOI":"10.1038\/nm0705-720"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Chandran K, Sullivan NJ, Felbor U,et al.Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.Science2005; 308 : 1643\u20135.","DOI":"10.1126\/science.1110656"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Jones SM, Feldmann H, Stroher U,et al.Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.Nat Med2005; 11 : 786\u201390.","DOI":"10.1038\/nm1258"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin.Proc Natl Acad Sci USA1998; 95 : 5762\u20137.","DOI":"10.1073\/pnas.95.10.5762"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Volchkov VE, Becker S, Volchkova VA,et al.GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.Virology1995; 214 : 421\u201330.","DOI":"10.1006\/viro.1995.0052"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Volchkov VE, Volchkova VA, Muhlberger E,et al.Recovery of infectious Ebola virus from complementary DNA : RNA editing of the GP gene and viral cytotoxicity.Science2001; 291 : 1965\u20139.","DOI":"10.1126\/science.1057269"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Dutch RE, Jardetzky TS, Lamb RA. Virus membrane fusion proteins : biological machines that undergo a metamorphosis.Biosci Rep2000; 20 : 597\u2013612.","DOI":"10.1023\/A:1010467106305"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Weissenhorn W, Dessen A, LJ Calder,et al.Structural basis for membrane fusion by enveloped viruses.Mol Membr Biol1999; 16 : 3\u20139.","DOI":"10.1080\/096876899294706"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Takada A, Robison C, Goto H,et al.A system for functional analysis of Ebola virus glycoprotein.Proc Natl Acad Sci USA1997; 94 : 14764\u20139.","DOI":"10.1073\/pnas.94.26.14764"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses : identification of receptor-deficient cell lines.J Virol1998; 72 : 3155\u201360.","DOI":"10.1128\/JVI.72.4.3155-3160.1998"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Garbutt M, Liebscher R, Wahl-Jensen V,et al.Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.J Virol2004, 78 : 5458\u201365.","DOI":"10.1128\/JVI.78.10.5458-5465.2004"},{"key":"R15","unstructured":"Feldmann H, Jones SM, Schnittler HJ, Geisbert T. Therapy and prophylaxis of Ebola virus infections.Curr Opin Investig Drugs2005; 6 : 823\u201330."},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Baize S, Leroy EM, Georges-Courbot MC,et al.Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.Nat Med1999; 5 : 423\u20136.","DOI":"10.1038\/7422"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Baize S, Leroy EM, Georges AJ,et al.Inflammatory responses in Ebola virus-infected patients.Clin Exp Immunol2002; 128 : 163\u20138.","DOI":"10.1046\/j.1365-2249.2002.01800.x"},{"key":"R18","unstructured":"Grolla A, Lucht A, Dick D,et al.Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.Bull Soc Pathol Exot2005; 98 : 205\u20139."},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Lupton HW, Lambert RD, Bumgardner DL,et al.Inactivated vaccine for Ebola virus efficacious in guinea pig model.Lancet1980; 2 : 1294\u20135.","DOI":"10.1016\/S0140-6736(80)92352-1"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Geisbert TW, Pushko P, Anderson K,et al.Evaluation in nonhuman primates of vaccines against Ebola virus.Emerg Infect Dis2002; 8 : 503\u20137.","DOI":"10.3201\/eid0805.010284"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Hevey M, Negley D, Pushko P,et al.Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.Virology1998; 251 : 28\u201337.","DOI":"10.1006\/viro.1998.9367"},{"key":"R22","unstructured":"Gilligan JK, Geisbert JB, Jahrling PB, Anderson K. Assessment of protective immunity conferred by recombinant VACV to guinea pigs challenged with Ebola virus. In : Brown F, Burton D, Doherty P,et al., edS.Vaccines. Cold Spring Harbor (NY) : Cold Spring Harbor Laboratory Press, 1997 : 87\u201392."},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Warfield KL, Bosio CM, Welcher BC,et al.Ebola virus-like particles protect from lethal Ebola virus infection.Proc Natl Acad Sci USA2003; 100 : 15889\u201394.","DOI":"10.1073\/pnas.2237038100"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Warfield KL, Swenson DL, Negley DL,et al.Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.Vaccine2004; 22 : 3495\u2013502.","DOI":"10.1016\/j.vaccine.2004.01.063"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Swenson DL, Warfield KL, Negley DL,et al.Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.Vaccine2005; 23 : 3033\u201342.","DOI":"10.1016\/j.vaccine.2004.11.070"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Vanderzanden L, Bray M, Fuller D,et al.DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.Virology1998; 246 : 134\u201344.","DOI":"10.1006\/viro.1998.9176"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Xu L, Sanchez A, Yang Z,et al.Immunization for Ebola virus infection.Nat Med1998; 4 : 37\u201342.","DOI":"10.1038\/nm0198-037"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Sullivan NJ, Sanchez A, Rollin PE,et al.Development of a preventive vaccine for Ebola virus infection in primates.Nature2000, 408 : 605\u20139.","DOI":"10.1038\/35046108"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Kobinger GP, Feldmann H, Zhi Y,et al.Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.Virology2006; 346 : 394\u2013401.","DOI":"10.1016\/j.virol.2005.10.042"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Sullivan NJ, Geisbert TW, Geisbert JB,et al.Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.Nature2003; 424 : 681\u20134.","DOI":"10.1038\/nature01876"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"McKenna PM, McGettigan JP, Pomerantz RJ,et al.Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.Curr HIV Res2003; 1 : 229\u201337.","DOI":"10.2174\/1570162033485320"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Geisbert TW, Jones S, Fritz EA,et al.Development of a new vaccine for the prevention of Lassa fever.PLoS Med2005; 2 : e183.","DOI":"10.1371\/journal.pmed.0020183"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2006224405\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T02:29:04Z","timestamp":1592360944000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2006224405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":32,"journal-issue":{"issue":"4"},"alternative-id":["medsci2006224p405"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2006224405","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}